- Home
- AGNC vs QGEN Comparison
AGNC vs QGEN Comparison
Compare AGNC & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AGNC | QGEN |
|---|---|---|
| Founded | 2008 | 1986 |
| Country | United States | Netherlands |
| Employees | 54 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.6B | 10.2B |
| IPO Year | N/A | 1998 |
Fundamental Metrics
Financial Performance| Metric | AGNC | QGEN |
|---|---|---|
| Price | $10.91 | $39.42 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 8 |
| Target Price | $11.03 | ★ $45.76 |
| AVG Volume (30 Days) | ★ 12.7M | 2.2M |
| Earning Date | 04-20-2026 | 05-06-2026 |
| Dividend Yield | ★ 13.13% | 7.17% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $0.33 | $8.18 |
| Revenue Next Year | $1.16 | $5.71 |
| P/E Ratio | ★ $7.69 | $24.01 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.08 | $32.53 |
| 52 Week High | $12.19 | $57.82 |
Technical Indicators
Market Signals| Indicator | AGNC | QGEN |
|---|---|---|
| Relative Strength Index (RSI) | 64.77 | 63.87 |
| Support Level | $10.64 | $38.80 |
| Resistance Level | $10.90 | $49.27 |
| Average True Range (ATR) | 0.17 | 0.80 |
| MACD | 0.06 | 0.26 |
| Stochastic Oscillator | 94.08 | 90.18 |
Price Performance
Historical ComparisonAbout AGNC AGNC Investment Corp.
AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage, or real estate markets.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).